Business

Labcorp Appoints Victor Bulto to Board of Directors

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the appointment of Victor Bulto, a seasoned pharmaceutical executive and member of Novartis' executive leadership team, to its Board of Directors, effective December 1, 2025.

articleLabcorp Holdings Inc.November 24, 20252/company/laboratory-corporation-of-america-holdings/news/labcorp-appoints-victor-bulto-board-133000578
Labcorp Appoints Victor Bulto to Board of Directors

About this update from Labcorp Holdings Inc.

[{"type":"text","content":"Bulto, President, U.S. of Novartis, brings global healthcare leadership and growth track record to support Labcorp's long-term strategy","length":139,"tagName":"p","attribs":{}},{"type":"text","content":"BURLINGTON, N.C., Nov. 24, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the appointment of Victor Bulto, a seasoned pharmaceutical executive and member of Novartis' executive leadership team, to its Board of Directors, effective December 1, 2025.","length":341,"tagName":"p"},{"type":"image","alt":"Victor Bulto","displaySize":"","headline":null,"caption":"Victor Bulto","className":"","disableSlideshowImg":false,"size":{"original":{"width":385,"height":400,"url":"https://media.zenfs.com/en/prnewswire.com/9f2b77521046030fd7fdaf1b75a3767e"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/AZXxU5tyfDa.nZ2EzNaUSQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTczMjtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/9f2b77521046030fd7fdaf1b75a3767e","width":385,"height":400}},"href":"https://mma.prnewswire.com/media/2829852/Labcorp_Victor_Bulto.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Bulto is an accomplished global executive with 25 years of experience in healthcare, and a proven track record of leading large, complex organizations across the U.S. and Europe. He currently oversees Novartis' U.S. business—a $20+ billion operation—with responsibility across four key therapeutic areas: oncology, immunology, neuroscience, and cardiovascular-renal-metabolic. Throughout his career at Novartis, Bulto has shaped bold strategies and delivered commercial excellence, enabling businesses to stay ahead amid intensifying regulatory and market pressures. He brings deep expertise in transformation, harnessing technology and automation to simplify processes, drive efficiency, and build future-ready operating models. By anticipating opportunities and building toward them, he drives progress at the evolving intersection of healthcare innovation and consumer expectations, creating new pathways for patient-centered care.","length":943,"tagName":"p"},{"type":"text","content":""Victor's appointment to our Board underscores Labcorp's focus on long-term growth through innovation and global healthcare leadership," s...

More updates from Labcorp Holdings Inc.

Victor BultoLabcorpBultotherapeutic areasNovartishealthcare innovationpharmaceutical executiveNYSEglobal healthcare